Evidence map›Paper›PMID 37446758›Full record

ReviewMolecules (Basel, Switzerland)2023

Photodynamic Therapy: From the Basics to the Current Progress of

Eurico Lima, Lucinda V Reis

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Unsymmetrical β-Fused Blatter Radical Zinc Phthalocyanines.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  7. Article
  8. Review
  9. Fluorescent Albumin-BindingInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Photodynamic Inactivation ofBiomacromolecules · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eurico LimaCQ-VR-Chemistry Centre of Vila Real, University of Trás-os-Montes and Alto Douro, Quinta de Prados, 5001-801 Vila Real, Portugal.ORCID 0000-0002-9402-8949
Lucinda V ReisCQ-VR-Chemistry Centre of Vila Real, University of Trás-os-Montes and Alto Douro, Quinta de Prados, 5001-801 Vila Real, Portugal.ORCID 0000-0001-5654-9359
University of Trás-os-Montes and Alto Douro · PT

Funding

COMPETE 2020 POCI-01-0145-FEDER-007491Fundação para a Ciência e Tecnologia SFRH/BD/147645/2019Fundação para a Ciência e Tecnologia UIDB/00709/2020Fundação para a Ciência e Tecnologia UID/QUI/UI0616/2019
6 · The paper itself

Abstract

Photodynamic therapy, an alternative that has gained weight and popularity compared to current conventional therapies in the treatment of cancer, is a minimally invasive therapeutic strategy that generally results from the simultaneous action of three factors: a molecule with high sensitivity to light, the photosensitizer, molecular oxygen in the triplet state, and light energy. There is much to be said about each of these three elements; however, the efficacy of the photosensitizer is the most determining factor for the success of this therapeutic modality. Porphyrins, chlorins, phthalocyanines, boron-dipyrromethenes, and cyanines are some of the

Indexed as

NeoplasmsPhotochemotherapyHumansPhotosensitizing AgentsPhotosensitizing AgentsN-heterocyclic-based dyesphotodynamic therapyphotosensitizers

Identifiers

PMID37446758
PMCPMC10343694
OpenAlexW4382599519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.